Research News
Research News
-
The Many Options of Preventing HIV with PrEP
From daily pills to long-acting injectables, advances in PrEP options address people’s diverse needs with a range of choices to prevent HIV infection.
-
Curing HIV—How Far Have We Come?
It can be hard to keep track of the various cases of HIV having been cured or controlled in the absence of antiretroviral therapy. amfAR has put together a helpful summary.
-
Daily Updates from the 2026 International AIDS Conference
Follow daily updates from the 27th International AIDS Conference, including amfAR news, HIV cure research, prevention advances, and major scientific breakthroughs.
-
The Next Step on the Path to an HIV Cure
Building on decades of CCR5 discoveries, amfAR grantee Dr. Jonah Sacha is advancing a new strategy to target the virus by blocking a key protein.
-
A Rising Tide Lifts All Boats: The Mutual Benefit of Investment in HIV and Cancer Research
New investments by amfAR in cancer immunology research have the potential to not only improve global health but also inform HIV cure research.
-
HIV, Brain Health Research, and How It Could Benefit Everyone
Studying aging-related conditions in people living with HIV could improve existing treatments and facilitate discovery of new interventions across other diseases.
-
Behind the Breakthrough: amfAR Fellow Spearheads Major HIV CRISPR Study
Former Krim fellow and amfAR Research Council member Dr. Ujjwal Rathore shares his journey into HIV research, including new CRIPSR study breakthrough.
-
Best Supporting Actors: Other Immune Cells Shaping the Future of HIV Research
Along with T cells, researchers are studying B cells, natural killer (NK) cells, and macrophages to discover how immune cells might work in new HIV therapies.
-
Remembering Loreen Willenberg, HIV Advocate Who Expanded the Boundaries of Cure Research
Loreen Willenberg was a pioneering HIV advocate and elite controller whose unique immune response helped advance HIV cure research.
-
Innovation at the Intersections of HIV and Brain Health
Dr. Andrea Gramatica, VP of Research, and Dr. Kelsey Hopland, Program Officer, Research, discuss a new set of questions about brain health as people age with HIV and the possible answers found in scientific advances.
-
The Role of Killer T Cells in an HIV Cure Strategy
An amfAR-supported HIV cure study investigates the timing of HIV-specific CD8+ “killer” T cell responses and the suppression of HIV reservoirs.
-
What’s on the Treatment and Cure Horizon for HIV and Cancer?
Researchers testing innovative technologies and therapeutic strategies that have applications across cancer and HIV are making meaningful progress.
-
The Promise of Immunotherapy to Cure HIV
A groundbreaking amfAR-funded HIV cure study using immunotherapy leads to potential breakthroughs in controlling the virus long-term.
-
How T Cells Are Defining the Future of HIV Therapies and Beyond
Research into T cells holds the potential to make advances in HIV therapies and the treatment of conditions such as cancer and autoimmune diseases.
-
“Elite Controllers” Provide Clues for an HIV Cure Strategy
Researchers look to “elite controllers,” people with a natural ability to control HIV, for more answers about the role of immunity in an HIV cure.